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Abstract
In vitro studies have demonstrated that cysteine groups present in most of the steroid receptors play an essential role in the
steroid binding process as well as in the ability of this superfamily of signaling proteins to function as transcription factors.
However, there is poor experimental evidence, if any, which demonstrates that under conditions of oxidative stress the steroid
receptors in general, and the mineralocorticoid receptor in particular, are affected in vivo in a similar fashion as has been
described for cell-free systems or cells in culture. In the present work we report that when mice are exposed to oxidative stress
by treatment with L-buthionine-(S,R)-sulfoximine (L-(S,R)-BSO), a glutathione depleting agent, the aldosterone-dependent
mineralocorticoid biological response (measured as sodium retention and potassium elimination) was diminished in a directly
proportional manner with respect to the depletion of renal glutathione. Accordingly, the steroid binding capacity of the
mineralocorticoid receptor was also abrogated, whereas the receptor protein level remained unchanged. The harmful effects
observed in mice after glutathione depletion were efficiently prevented by co-treatment with glutathione monoethyl ester.
Similar inhibition in the steroid binding capacity was also generated in vitro by receptor alkylation and receptor oxidation,
an effect which was prevented in the presence of reducing agents. Since the glutathione deficit generated in vivo by treatment
with L-(S,R)-BSO did not significantly affect other renal proteins which are known to be required for the mineralocorticoid
mechanism of action, we suggest that in renal cells a low redox potential exerts drastic and uncompensated inhibition of the
receptor-mediated mineralocorticoid biological response. This effect was ascribed to the loss of steroid binding capacity of
oxidized receptor, most likely by modification of essential cysteines as supported by experiments where a decreased number
of reactive thiols and reduced covalent binding of thiol-reactive ligand were evidenced on immunopurified receptor after in
vivo treatment with L-(S,R)-BSO . ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The mineralocorticoid receptor (MR) is a member
of a superfamily of closely related intracellular recep-
tors which function as ligand-activated transcription
factors [1]. Aldosterone (ALDO) and 11-deoxycorti-
costerone are the most potent physiological steroids
with mineralocorticoid properties, whereas glucocor-
ticoids such as cortisol and corticosterone are also
capable of triggering a MR-dependent biological re-
sponse under certain conditions. Upon steroid bind-
ing, corticosteroid receptors transform and translo-
cate into the nucleus of the target cell in a process
where the dissociation of the 90-kDa heat shock pro-
tein, hsp90, derepresses the transcriptional activity of
the receptor. The temporal sequence for receptor
transformation and translocation upon steroid bind-
ing is unknown, and the heuristic dogma that hsp90
should be dissociated from the receptor before recep-
tor tra⁄cking into the nucleus is under revision [2^4].
Once the chaperone complex is dissociated, the DNA
binding domain of the receptor can bind to cognate
responsive elements in the nucleus triggering the spe-
ci¢c biological response.
In epithelial cells, ALDO is the main agent respon-
sible for the regulation of the homeostasis of the
internal medium by a¡ecting the electrolyte balance
through the activation of the MR. Some other fac-
tors can also a¡ect sodium elimination via their spe-
ci¢c receptors, i.e. arginine vasopressin [5] or atrial
natriuretic peptides [6]. Nevertheless, the contribu-
tion of ALDO in the maintenance of the electrolyte
balance is the most signi¢cant. The mineralocorticoid
e¡ect is characterized by signi¢cant sodium ^ and
water ^ retention as well as potassium and proton
elimination. From the quantitative point of view, the
ALDO-dependent sodium retaining e¡ect is much
more important than urine acidi¢cation or kaliuresis
(see [7] for a review and results shown in this work).
As previously noted, endogenous pregnanesteroids
with typical glucocorticoid properties (i.e. cortisol
and corticosterone) also possess potential mineralo-
corticoid biological activity. But under physiological
conditions these ligands are excluded from competi-
tion for the MR due to the inactivating action of the
enzyme 11L-hydroxysteroid dehydrogenase that oxi-
dizes the C11-hydroxyl group to 11-keto inactive de-
rivatives [8]. Since ALDO compromises its C11-hy-
droxyl group in a hemiketalic bridge, it is not a
substrate of 11L-hydroxysteroid dehydrogenase. Cer-
tain physiological derivatives of progesterone such as
11L-hydroxyprogesterone and 11-ketoprogesterone
inhibit the metabolizing activity of 11L-hydroxyste-
roid dehydrogenase, so that glucocorticoids acquire
mineralocorticoid properties. Therefore, a regulatory
role for these progesterone derivatives has been
postulated for the maintenance of the electrolyte bal-
ance [9]. In all the aforementioned instances, the ste-
roids exert their side e¡ects through the activation of
the mineralocorticoid receptor, this protein being a
key factor for the biochemical events which lead to
the maintenance of the electrolyte balance.
Kidney MR is a phosphoprotein [10,11] which is
extremely unstable in cell-free systems. Renal MR is
particularly sensitive to oxidants in a low potential
redox medium [12]. According to this feature and
due to the inhibitory e¡ect of alkylating reagents
on steroid binding, an essential role for cysteines
was inferred for both rat [12,13] and human MR
(hMR) [14]. This inference was con¢rmed in a recent
work by site-directed mutagenesis of Cys849 and
Cys942 of the hMR [15].
Both the glucocorticoid receptor (GR) and the
MR lose their ability to bind steroid upon in vitro
treatment with sulfhydryl reagents. Interestingly, na-
tive MR seems to be extremely more sensitive to this
inactivation than native GR since a concentration as
low as 10 WM of sulfhydryl reagent is su⁄cient to
abolish one-third of the steroid binding capacity of
the MR. In contrast, at least a 10-fold higher con-
centration of thiol reactive reagent is required to ob-
tain similar inhibition with the GR. Accordingly, re-
nal MR is highly sensitive to inactivation by metal
ions (both in vitro and in vivo), particularly those
that belong to the hard ion type (i.e. Hg2, Cd2,
Cu2) which are highly reactive with thiol groups
in agreement with the soft and hard theory for metal
ion reactivity [13].
Preserving protein thiols in a reduced form is an
important challenge for the cell. As a defense against
oxidative metabolism, cells possess the ability to syn-
thesize quenchers that intervene either as sacri¢cial
molecules in redox cycles or as speci¢c enzymes that
act directly on the oxygen radicals forming products
that are less o¡ensive. There are at least three major
antioxidant enzymatic systems: superoxide dismu-
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tase, catalase, and glutathione peroxidase [16]. Super-
oxide dismutases convert superoxide anion into
H2O2 and O2, catalase catalyzes the dismutation of
H2O2, and glutathione peroxidase catalyzes the re-
ductive destruction of oxidized compounds using re-
duced glutathione as an electron donor.
Glutathione (GSH) is a tripeptide (Q-Glu-CysH-
Gly) widely distributed in animals, plants and micro-
organisms [17,18]. It is typically present in high levels
(mM) and is thus both the most prevalent intracel-
lular thiol and the most abundant low molecular
weight oligopeptide. GSH is not required in the
diet, but is synthesized in virtually all animal cells
by the sequential actions of two enzymes: Q-glutam-
yl-cysteine synthetase and GSH synthetase. GSH is
exported continuously from the cell and its degrada-
tion occurs extracellularly [19]. GSH de¢ciency can
be produced in vivo by administering animals a tran-
sition state inhibitor of Q-glutamylcysteine synthe-
tase, L-buthionine-(S,R)-sulfoximine (L-(S,R)-BSO)
[20,21]. Therefore, cellular GSH level decrease after
L-(S,R)-BSO is given because the cellular export of
GSH continues in the absence of signi¢cant intracel-
lular synthesis [18].
The requirement of a low redox potential for ste-
roid binding to the MR has been previously studied
in vitro, mostly in structural studies which ascribed
the inactivation of the MR to the crucial role played
by certain amino acids in the receptor, most likely
cysteine. Whether the inactivation of MR also occurs
in vivo under circumstances of oxidative stress is
uncertain. In the present work, we report that
when renal GSH is depleted by treatment of mice
with L-(S,R)-BSO, both the mineralocorticoid biolog-
ical response and the ALDO binding capacity of
kidney MR are abrogated. We also provide direct
evidence that the inhibition of these two processes
is correlated with the oxidation of thiol groups of
the MR.
2. Materials and methods
2.1. Reagents
[1,2-3H]ALDO (50.0 Ci/mmol), [6,7-3H]dexa-
methasone (DEX) (40.5 Ci/mmol), [6,7-3H]DEX-me-
sylate (35.5 Ci/mmol), and radioinert ZK91587 were
purchased from New England Nuclear (Boston,
MA, USA). [21,22-3H]Ouabain (35.0 Ci/mmol) was
from Amersham (Arlington Heights, IL, USA).
[14C]Amiloride was synthesized with [14C]methyl io-
dide (Amersham, 28 Ci/mmol) and puri¢ed by thin
layer chromatography as described by Lazorick et al.
[22]. Radioinert ALDO, DEX, L-(S,R)-BSO, reduced
GSH, GSH monoethyl ester, dithionitrobenzoic acid
(DTNB), N-ethylmaleimide (NEM), diethylmaleate
(DEM), and amiloride were from Sigma Chemical
Co. (St. Louis, MO, USA). RU28362 and RU486
were a kind gift from Roussell-Uclaf (Romainville,
France). The rabbit pAbhMR antibody generated
against the hMR amino acids 1^719 was a generous
gift of Dr. G. Litwack and Dr. N. Robertson from
the Je¡erson Cancer Institute (Philadelphia, PA,
USA). Donkey anti-rabbit IgG-horseradish per-
oxidase was from Pierce (Rockford, IL, USA).
L-(S,R)-BSO was recrystallized from 80% (v/v) etha-
nol and fractionally crystallized from water to obtain
the less soluble diastereoisomer L-(R)-BSO as de-
scribed by Mafirtensson et al. [21].
2.2. Determination of mineralocorticoid activity
Bioassays were always carried out according to the
ethical requirements for animal handling ruled by
national authority. Male BALB/c mice weighing
V15 g underwent adrenalectomy 5 days prior to
the experiments. Mice were fed Purina Diet 1 and
0.9% sodium chloride and fresh water ad libitum.
Saline solution also contained 50 Wg/ml of DEX.
This saline/DEX solution was replaced by saline sol-
ution without steroid the night before the experi-
ment. Food was also removed at this time. All
liquids were removed 4 h before ALDO was admin-
istered. For the bioassays, we followed a method
previously described in detail for rats [23,24]. Brie£y,
mice were anesthetized with ether and their urinary
bladders were emptied by suprapubic pressure. The
penis was ligated to favor urine retention and mice
were given intramuscular injections of ALDO dis-
solved in ethanol:propylene glycol:0.9% NaCl solu-
tion (1:2:37) at a dose equal to 2 Wg steroid per 100 g
of body weight for most of the experiments. Controls
were injected with vehicle only. A subcutaneous in-
jection of 3 ml of 0.9% NaCl solution was also given.
Three hours later, mice were anesthetized again and
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urine was aspirated from the bladder. Urinary so-
dium and potassium levels were measured by £ame
photometry. Systematically, plasma and urinary cre-
atinine were also measured to evaluate the endoge-
nous creatinine clearance rate.
2.3. In vitro steroid binding assays
Kidneys from adrenalectomized mice were excised
after extensive perfusion with ice-cold phosphate sa-
line solution. Renal cortex^medulla interphases were
homogenized in two volumes of a bu¡er containing
25 mM Tris, 10 mM EDTA, 20 mM sodium molyb-
date, 20% glycerol, 2 mM dithiothreitol (DTT), 0.1
mM phenylmethylsulfonyl £uoride, 2 IU/ml aproti-
nin, 30 Wg/ml trypsin-chymotrypsin inhibitor, at pH
7.4. The homogenates were centrifuged at 67 000Ug
for 45 min at 0‡C, and the supernatant from this
centrifugation was referred to as the cytosol. Kidney
cytosol was incubated for 10 h at 0‡C in the presence
of 10 nM [3H]ALDO and 1.0 WM RU28362 to pre-
vent cross-reaction with the GR. A 1000-fold excess
of radioinert ALDO was used to determine the non-
speci¢c binding (20^30% of the total). The standard
reaction volume used for these studies was 0.5 ml.
Bound steroid was separated from free by adding
1 volume of 2% charcoal coated with 0.2% dextran
15^20. Scatchard plots were performed by incubation
of kidney cytosol with increasing concentrations of
[3H]ALDO (from 1U10310 M to 5U1038 M) as de-
scribed in previous works [24,25].
Steroid binding to the GR was measured in cyto-
sols incubated with 50 nM of [3H]DEX in the pres-
ence of 10.0 WM ZK91587 to prevent cross-reaction
with the MR. The non-speci¢c binding was measured
in the presence of 1000-fold of radioinert DEX (10^
20% of the total).
2.4. Sulfhydryl modi¢cation in kidney cytosol
Kidney cytosol was obtained from adrenalectom-
ized mice in bu¡er lacking DTT. The MR was inac-
tivated by alkylation with 0.1 mM or 1.0 mM of
NEM or DTNB for 1 h at 8‡C. MR oxidation was
induced with 5% (v/v) H2O2 for 30 min at 8‡C, in the
presence of 1 mM NaN3 to inhibit endogenous cata-
lases. A steroid binding assay with 10 nM
[3H]ALDO and 1.0 WM RU28362 was then per-
formed. When the reversion of thiol blocking was
attempted, a preincubation of 30 min on ice with
10 mM DTT was conducted prior to the steroid
binding assay, which was also performed in a me-
dium containing DTT.
2.5. Depletion of glutathione
L-(S,R)-BSO and L-(R)-BSO were dissolved in
ethanol:propylene glycol:0.9% NaCl solution
(3:5:32). Intramuscular injections were given to
adrenalectomized mice at intervals of 12 h (8.00
and 20.00 h) during 5 days (2.5 mmol BSO/kg
body weight at each injection or 5 mmol/kg/day).
In treatments where GSH or GSH monoethyl ester
were also injected, three daily doses of 2 mmol/kg per
injection were also given (9.00, 15.00, and 21.00 h).
Acute treatments with DEM (dissolved in the afore-
described vehicle) were conducted by injection of
3 mmol/kg every 60 min for a total period of 2 h
(three doses). After the third dose, the assays to eval-
uate the mineralocorticoid response were performed.
2.6. Glutathione determinations
Blood samples were taken by heart puncture and
collected in 5 mM EDTA. Plasma was separated
quickly, acidi¢ed with 1% (w/v) 5P-sulfosalicylic
acid to prevent autooxidation of GSH, centrifuged
at 1000Ug for 5 min, and plasma was used to mea-
sure the GSH concentration. When GSH levels were
measured in other tissues, the organs were perfused
with ice-cold saline solution, excised, and homoge-
nized in 5 volumes of 5% (w/v) 5P-sulfosalicylic
acid. The homogenates were centrifuged at 8100Ug
for 10 min and the supernatants were used to mea-
sure GSH levels. Total GSH was measured by the
GSH disul¢de reductase^DTNB recycling enzymatic
assay as described by Anderson [26].
2.7. In vivo steroid binding assays
Three groups of adrenalectomized mice were
treated for 5 days (long-term treatment) with either
L-(S,R)-BSO, L-(R)-BSO or vehicle. A fourth group
was treated with a single dose of 5 mmol L-(S,R)-
BSO/kg (acute treatment). We used a modi¢cation
of a previously described assay for in vivo ALDO
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binding to kidneys [23]. Animals were given intraper-
itoneal injections of 10 WCi [3H]ALDO and 20 Wg of
RU28362 in saline. After acute treatment, mice were
injected with [3H]ALDO 5 h after the injection with
L-(S,R)-BSO. Kidneys were excised 20 min after the
radioactivity was injected and homogenized in the
same bu¡er described above for the in vitro assays,
but without the addition of DTT. Kidney cytosol
was adsorbed with charcoal/dextran to clarify free
[3H]ALDO, and the remaining radioactivity was
measured in the supernatant. The non-speci¢c bind-
ing (V50% of the total binding) was measured by
co-injection of 30 Wg of radioinert ALDO and sub-
tracted from the total. In some experiments, in vivo
labelled cytosol was reincubated in vitro with 10 nM
[3H]ALDO and 1.0 WM RU28362 in the presence of
2 mM DTT.
2.8. Immunoprecipitation of renal MR
To avoid the slight cross-reactivity of pAbhMR
antibody with the GR, renal cytosol was precleared
with BuGR2 antibody for 1 h at 4‡C as described in
detail [11]. The resultant supernatant was immu-
noadsorbed with pAbhMR antibody against MR
(or non-immune rabbit serum) bound to protein A-
Sepharose for 2 h at 4‡C, and washed ¢ve times with
ice-cold bu¡er containing 10 mM Tris, 1 mM EDTA,
10% glycerol, 0.1% Triton X-100, 0.5 M NaCl, at pH
7.5. Proteins were resolved in a 9% polyacrylamide-
SDS gel, electrotransferred to an Immobilon mem-
brane, and probed with a solution of 0.1% pAbhMR.
Donkey anti-rabbit antibody labelled with either 125I
or horseradish peroxidase was used to visualize im-
munoreactive bands.
When sulfhydryl groups of the MR were quanti-
¢ed, immunopellets obtained as described above
were stripped of proteins associated with the receptor
by incubation with bu¡er containing 0.5 M NaCl (1 h
at 0‡C). Stripped immunopellets were washed three
times with 80 mM phosphate bu¡er containing 1 mM
EDTA (pH 8.0). Total protein sulfhydryl was mea-
sured as described by Habeeb [27] with Ellman’s re-
agent (made in the same bu¡er used to wash the
pellets) supplemented with 2% SDS.
2.9. Receptor labelling with [3H]DEX-mesylate
Mice were treated with L-(S,R)-BSO for 5 days as
described above. Kidneys were excised and homoge-
nized as described for binding assays, except that
DTT was omitted from the bu¡er. Cytosol was la-
belled for 3 h at 0‡C with 300 nM of [3H]DEX-me-
sylate in the absence (total binding) or presence
(non-speci¢c binding) of 50 WM radioinert DEX.
To avoid labelling of the GR, the incubation medium
was supplemented with 30 WM RU486. Free steroid
was adsorbed with 1% charcoal/0.1% dextran, and
the resultant labelled MR was immunoadsorbed
and resolved by electrophoresis as described above.
2.10. Isolation of kidney tubules
Distal kidney tubules were obtained according to
Table 1
GSH levels in mouse tissues after treatment with L-(S,R)-BSO
Tissue GSH, Wmol/g of tissue (% of control)
Control L-(S,R)-BSO L-(R)-BSO
Plasmaa 20.2 þ 0.8 4.7 þ 0.8 (23.2) 17.5 þ 0.5 (86.6)
Kidney 2.2 þ 0.2 0.4 þ 0.1 (18.2) 1.8 þ 0.2 (81.2)
Hippocampus 1.6 þ 0.3 1.0 þ 0.2 (62.5) 1.4 þ 0.3 (87.5)
Parotid 1.7 þ 0.4 0.6 þ 0.3 (35.3) 1.5 þ 0.2 (88.2)
Distal Colon 2.1 þ 0.4 0.5 þ 0.2 (23.8) 1.8 þ 0.3 (85.7)
Heart 2.3 þ 0.2 0.4 þ 0.1 (17.4) 2.0 þ 0.2 (87.0)
Liver 6.5 þ 0.5 2.2 þ 0.3 (33.8) 5.1 þ 0.3 (78.5)
Lung 1.9 þ 0.2 0.6 þ 0.2 (31.6) 1.6 þ 0.2 (84.2)
Adrenalectomized mice were injected (i.m.) for 5 days at intervals of 12 h with either 5.0 mmol/kg/day of L-(S,R)-BSO, L-(R)-BSO, or
vehicle (control). Organs were excised, homogenized, and GSH levels measured. Results represent means þ S.E.M. for ¢ve mice per
group.
aPlasma concentrations are given in WM.
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Gesek et al. [28]. Brie£y, mouse kidneys were per-
fused with Krebs^Henseleit solution containing
1100 U/ml of collagenase and 400 U/ml hyaluroni-
dase, excised, and cut into sagittal slices of V2 mm
thick. Cortices were carefully removed, minced, and
incubated with collagenase and hyaluronidase for 15
min at 37‡C with continuous shaking (100 rpm)
under a 95% O2/5% CO2 atmosphere. The suspen-
sion of dispersed tubules was separated on Percoll
isoosmotic gradient (previously bubbled with 95%
O2) for 10 min at 17 500Ug (4‡C). Bands enriched
in distal tubules (density 1.020^1.025 g/ml) were
pooled and immediately examined under the micro-
scope. Isolated tubules were ¢nally placed in Dulbec-
co’s modi¢ed Eagle’s medium supplemented with
10% mouse serum. Viability was estimated by both
trypan blue exclusion and lactate dehydrogenase
leakage. Distal tubules were used to evaluate several
parameters according to methods previously de-
scribed in the literature: 11L-hydroxysteroid dehy-
drogenase activity as described [9], [14C]amiloride
binding capacity according to Sariban-Sohraby et
al. [29], and citrate synthase activity, Na/K-ATPase
activity, and [3H]ouabain binding capacity as de-
scribed by Laplace et al. [30].
3. Results
3.1. Treatment with L-(S,R)-BSO generates a
systemic de¢ciency of GSH
Table 1 shows GSH levels in tissue preparations
obtained from several organs. Except liver, all organs
are targets for ALDO. Administration of L-(S,R)-
BSO led to decreasing GSH levels, whereas the in-
active diastereoisomer L-(R)-BSO was ine¡ective in
depleting GSH as compared with untreated controls.
The concentration of GSH ranged from V18% of
the control level for the most sensitive tissues (kidney
and heart), to V35% for the other studied tissues
(plasma, parotid gland, distal colon, liver, and
C
Fig. 1. Mineralocorticoid biological e¡ect in mice treated with
buthionine-sulfoximine. Adrenalectomized mice were treated for
5 days with 5.0 mmol/kg/day (administered in two injections
every 12 h) of either L-(S,R)-BSO (b) or the inactive diastereo-
isomer L-(R)-BSO (a). Vehicle alone was administered to con-
trols (F). Di¡erent doses of ALDO were then administered
(i.m.) as described in Section 2, urine was aspirated after 3 h
by bladder puncture, and sodium, potassium, and creatinine
were measured. Results show urinary elimination of electrolyte
as a function of the logarithm of the injected dose of ALDO
(mean þ S.E.M. of four experiments, each performed with four
animals per dose and per experimental condition). *Di¡erent
from controls at P6 0.001.
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lung). Levels of GSH in the hippocampus decreased
only 38%, probably as a consequence of the rela-
tively poor di¡usion of L-(S,R)-BSO across the
blood^brain barrier. Nevertheless, GSH levels are
signi¢cantly lower in the hippocampus from
L-(S,R)-BSO-treated animals than in untreated mice.
3.2. The mineralocorticoid function is inhibited in mice
treated with L-(S,R)-BSO
Fig. 1 depicts dose^response curves for the miner-
alocorticoid e¡ect on adrenalectomized mice injected
with several doses of ALDO. In control mice, the
rate of sodium retention reached a plateau at 1 Wg/
100 g dose. Consistent with the major role of ALDO
in controlling the electrolyte balance, only 16% of
sodium elimination with respect to mice injected
with vehicle was measured at that saturating dose
(Fig. 1A). As previously noted, the kaliuretic e¡ect
is less sensitive than the natriuretic e¡ect, and nearly
70% of increasing potassium elimination was measur-
ed (Fig. 1B). Therefore the Na/K ratio, a more
representative parameter of the mineralocorticoid ef-
fect, diminished 10-fold after treatment with agonist
(Fig. 1C).
Mice pretreated with 5 mmol/kg/day of L-(S,R)-
BSO, a selective inhibitor of GSH metabolism, ex-
hibited a signi¢cantly (P6 0.001) less e⁄cient miner-
alocorticoid e¡ect upon ALDO administration. As
can be seen in Fig. 1A, untreated mice show V2.5
times more sodium retention at doses v 0.1 Wg
ALDO. Accordingly, the ALDO-dependent kaliure-
sis is V30% less e¡ective (P6 0.001). As a conse-
quence, the Na/K ratio is about three times higher
than the values exhibited by controls (Fig. 1C). In
contrast, animals treated with the inactive diastereo-
isomer L-(R)-BSO showed no signi¢cant di¡erence
for both electrolytes with respect to the control
group.
Importantly, the endogenous creatinine clearance
rate remained constant (0.11 þ 0.04 ml/min) regard-
less of the treatment, demonstrating that if a dimin-
ished electrolyte elimination rate was measured, it
was due to the e¡ect of the steroid on the target
cell and not to changes in the mouse’s glomerular
¢ltration rate. Accordingly, the values of Na reten-
tion and K elimination were similar for all condi-
tions in animals which were not injected with ALDO.
3.3. The inhibition of the mineralocorticoid e¡ect and
the depletion of renal GSH are related in a
dose-dependent manner with the administration
of L-(S,R)-BSO
The previous experiments demonstrated that treat-
ment with L-(S,R)-BSO depletes tissue GSH and the
ALDO-dependent biological response is partially
abolished as well. In order to demonstrate a direct
link between these variables, a group of adrenalec-
tomized mice were treated with several doses of
L-(S,R)-BSO for 5 days, and then injected with 2 Wg
ALDO/100 g to ensure maximum sodium retention
and potassium elimination. Once samples of urine
were taken by bladder puncture, kidneys were ex-
cised and homogenized to determine the tissue
GSH concentration.
As can be seen in Fig. 2, renal GSH levels and
inhibition of the mineralocorticoid e¡ect show an
inverse relationship, suggesting that the low redox
potential generated in the tissue by treatment with
L-(S,R)-BSO may be responsible for the lack of a
proper biological response upon ALDO stimulation.
Importantly, this correlation is dose-dependent with
Fig. 2. Dependence of tissue GSH levels and inhibition of the
mineralocorticoid e¡ect on the dose of L-(S,R)-BSO. Daily total
doses of L-(S,R)-BSO ranging from 0 to 6 mmol/kg were given
to mice for 5 days in two injections every 12 h. 2 Wg of ALDO
per 100 g of body weight was then injected and the mineralo-
corticoid e¡ect measured as described for Fig. 1. After collect-
ing urine samples, kidneys were quickly removed, homogenized,
and the GSH tissue levels quanti¢ed. Results show the mean þ
S.E.M. of eight animals per treatment.
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the GSH depleting agent. Inasmuch as a 5 mmol/kg/
day dose exhibits almost maximum e¡ect, and be-
cause it was always well tolerated by the mice, we
selected this dose for the rest of the experiments
shown in this work.
3.4. E¡ect of acute treatment with L-(S,R)-BSO
The temporal e¡ect of a single intraperitoneal dose
of 5 mmol/kg L-(S,R)-BSO and L-(R)-BSO on renal
GSH content is shown in Fig. 3A. Maximum deple-
tion of GSH occurred 3 h after drug administration
and remained approximately constant for 6 h. Renal
GSH level recovered to similar values as those mea-
sured in the control after 15 h. On the other hand,
the inactive isomer L-(R)-BSO exhibited no e¡ect on
GSH renal content.
In order to evaluate whether acute depletion of
GSH also inhibits the ALDO-dependent mineralo-
corticoid e¡ect, a group of mice were pretreated
with 5 mmol/kg L-(S,R)-BSO for 5 h and another
group were pretreated during 5 days as described
for Fig. 1. Sodium and potassium elimination were
then measured after injection of a saturating dose of
2 Wg/100 g of ALDO. Fig. 3B shows that acute GSH
depletion also inhibited the mineralocorticoid biolog-
ical response in a similar manner as observed for
mice treated during 5 days.
Results depicted in Fig. 3 con¢rm that a dimin-
ished redox potential exerts deep e¡ects on the
ALDO-mediated mineralocorticoid response in kid-
ney. They also suggest that the consequences of a
long-term treatment on this in toto biological re-
sponse are the same as those observed in acute treat-
ment, making unlikely the in£uence of putative side
e¡ects on the mineralocorticoid response after 5 days
of GSH depletion.
3.5. GSH depletion decreases the steroid binding
capacity of the renal MR
Because glutathione depletion inhibited the
ALDO-dependent biological response, we analyzed
the in vivo renal steroid binding capacity of mouse
MR after treatment with buthionine sulfoximine.
Mice were pretreated with 5 mmol/kg L-(S,R)-BSO
for 5 h or 5 days, and were then injected (i.p.) with
10 WCi of [3H]ALDO and 20 Wg of RU28362 in sa-
line solution ( þ 30 Wg of radioinert ALDO). Under
these conditions, renal radioactivity reaches a maxi-
mum after 20 min post-injection (data not shown), so
kidneys were excised at this time. Cytosol was ob-
tained in bu¡er lacking DTT and cleared of free
[3H]ALDO by adsorption with charcoal/dextran.
Speci¢c binding was measured and the results are
depicted in Fig. 4A. Kidney cytosol obtained from
Fig. 3. Acute treatment with L-(S,R)-BSO. (A) Time course of
renal GSH levels after a single dose of L-(S,R)-BSO. GSH was
measured in mouse kidney cytosol after the indicated post-injec-
tion times of a single intraperitoneal dose of 5 mmol/kg
L-(S,R)-BSO (b) or 5 mmol/kg L-(R)-BSO (a). Results are
means þ S.E.M. (n = 5). (B) Mineralocorticoid e¡ect. Mice were
treated with 5 mmol/kg of L-(S,R)-BSO for 5 h or 5 days. Uri-
nary elimination of sodium (open bars) and potassium (black
bars) was measured after injection of a saturating dose of 2 Wg/
100 g of ALDO. Results are means þ S.E.M. (n = 8).
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mice pretreated with the inactive isomer L-(R)-BSO
(column B) showed similar speci¢c binding as the
controls treated with vehicle (column A), whereas
renal cytosol from animals treated for 5 h with
L-(S,R)-BSO showed nearly 45% lower steroid bind-
ing capacity (column C). Radiolabelled cytosols re-
incubated in vitro with 10 nM [3H]ALDO for 3 h at
0‡C showed no increase in the speci¢c radioactivity
bound to MR, indicating that the in vivo labelling
had saturated the renal MR binding capacity (data
not shown). When cytosol obtained from mice
treated in acute form with L-(S,R)-BSO was reincu-
bated in a bu¡er containing DTT, MR completely
recovered the steroid binding capacity to the same
levels as control (column D). This suggests that the
lack of steroid binding capacity exhibited by the MR
in this group of mice was due to a rapid oxidation of
MR in a GSH-depleted milieu (0.4 þ 0.2 Wmol GSH/g
of tissue). This observation also indicates that the
receptor protein should be present at normal levels
in kidney after the acute treatment with buthionine
sulfoximine, although it is unable to bind steroid
e⁄ciently. Column E shows a diminished steroid
binding capacity of kidney cytosols obtained from
mice treated for 5 days with L-(S,R)-BSO. This value
is not signi¢cantly di¡erent from the acute (5 h)
treatment. However, reincubation of cytosol with
[3H]ALDO in the presence of DTT failed to recover
fully the steroid binding capacity upon reduction of
oxidized proteins. Thus, a signi¢cant reduction of
25% in the steroid binding was measured. This may
be due to a change in the number of receptors able to
bind steroid or because the receptor lost a⁄nity for
the ligand. Therefore, we performed Scatchard plots
to evaluate these options. Fig. 4B shows that control
cytosol exhibits a steroid binding capacity of 48 þ 5
fmol/mg of protein whereas only 22 þ 5 and 26 þ 2
fmol/mg of protein were measured, respectively,
from 5 days and 5 h L-(S,R)-BSO-treated mice.
When these samples were preincubated on ice with
2 mM DTT for 30 min and the steroid binding assay
was then performed, the total number of receptors
was fully recovered in cytosol obtained from 5 h
treatment (53 þ 3 fmol/mg), whereas only a partial
recovery was obtained in cytosol from 5 day treat-
ment (36 þ 3 fmol/mg). The dissociation constants
Fig. 4. Steroid binding capacity of renal MR from treated mice. (A) In vivo labelling. Mice were treated with vehicle (column A),
L-(R)-BSO for 5 days (column B), L-(S,R)-BSO for 5 h (columns C and D) or for 5 days (columns E and F). Then, an intraperitoneal
injection of 10 WCi [3H]ALDO and 20 Wg RU28362 ( þ 30 Wg radioinert ALDO) was given, kidneys were removed after 20 min and
homogenized in bu¡er lacking DTT. Free [3H]ALDO was clari¢ed by adsorption with charcoal/dextran and the radioactivity was
measured in aliquots containing 5 mg of protein. In conditions D and F, the in vivo labelled cytosol was preincubated on ice with
2 mM DTT for 30 min, and then reincubated in vitro with 10 nM [3H]ALDO ( þ 1000-fold of radioinert ALDO) for 3 h at 0‡C in
the presence of 2 mM DTT. Results are means þ S.E.M. of four animals per group. *Di¡erent from condition A at P6 0.001. (B)
Scatchard plots. Kidney cytosol was obtained from mice treated with 5.0 mmol/kg/day of L-(S,R)-BSO for 5 days. Cytosol (5 mg of
protein) was labelled with increasing concentrations of [3H]ALDO for 3 h at 0‡C. Speci¢c binding was then measured. Conditions
are: cytosol from untreated mice (R) ; cytosol from L-(S,R)-BSO-treated mice for 5 days (a) or 5 h (b) ; cytosol from L-(S,R)-BSO-
treated mice for 5 days (E) or 5 h (F) which was incubated with 2 mM DTT on ice for 30 min and relabelled in vitro with
[3H]ALDO in the presence of the reducing reagent.
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measured for all conditions were nearly identical and
may be clustered around a mean value of 0.6 þ 0.2
nM. Previous experiments performed as control dem-
onstrated that L-(S,R)-BSO does not itself a¡ect the
ALDO binding to MR when the drug is added to the
incubation medium in a cell-free system.
These experiments demonstrate that the partial de-
crease of steroid binding capacity in L-(S,R)-BSO-
treated mice may be attributed to a loss in the num-
ber of renal binding sites rather than changes in the
a⁄nity constant of MR for ALDO.
3.6. Steroid binding capacity in di¡erent organs
We next asked if glutathione depletion is also able
to inhibit the MR binding capacity in target organs
other than kidney, as well as whether the GR is as
sensitive to such depletion as the MR. Mice were
treated for 5 h or 5 days with L-(S,R)-BSO and kid-
ney (control), liver (MR is not expressed in this or-
gan), lung, hippocampus, parotid, and distal colon
were excised, homogenized in bu¡er lacking DTT,
and a steroid binding assay was then performed on
cytosol fractions. Speci¢c binding to the MR was
measured with 10 nM [3H]ALDO ( þ 1000-fold ex-
cess of radioinert ALDO) in the presence of 1.0
WM RU28362 to block the GR, and 50 nM [3H]DEX
( þ 1000-fold excess of radioinert DEX) was used to
evaluate the GR steroid binding capacity. To prevent
the cross-reaction of DEX with the MR, 10 WM of
the speci¢c antimineralocorticoid ZK91587 was used.
Results are shown in Table 2.
As demonstrated before for kidney, treatment with
L-(S,R)-BSO signi¢cantly inhibited the ALDO bind-
ing to the MR in lung, parotid, and distal colon
(approximately 40% and 50% after 5 h and 5 days
of treatment, respectively). In contrast, hippocampus
exhibited lower sensitivity than the other target or-
gans. In e¡ect, only 26% of inhibition with respect to
the control was measured after 5 days of treatment
and no signi¢cant di¡erence was observed for acute
treatment. This observation in hippocampus parallels
the lower e⁄ciency of L-(S,R)-BSO to deplete GSH
in this tissue (Table 1). On the other hand, results
shown in Table 2 demonstrate that the GR is less
sensitive than the MR to the GSH depletion. No
signi¢cant di¡erences in DEX binding were obtained
after 5 h of treatment in kidney, lung, hippocampus,
parotid, and colon1, whereas only 20% inhibition
was observed in liver. Long-term treatment decreased
Table 2
E¡ect of L-(S,R)-BSO on the steroid receptor binding capacity of di¡erent organs
Tissue Receptor Control +L-(S,R)-BSO
5 h 5 days
Kidney MR 47 þ 6 28 þ 4a 23 þ 3a
GR 140 þ 15 121 þ 7 109 þ 15d
Liver MR Not detectable Not detectable Not detectable
GR 475 þ 38 377 þ 22b 296 þ 31a
Lung MR 16 þ 4 10 þ 1c 7 þ 3c
GR 185 þ 21 157 þ 13a 112 þ 9a
Hippocampus MR 75 þ 7 68 þ 9 55 þ 6d
GR 105 þ 12 109 þ 7 90 þ 6
Parotid MR 19 þ 2 12 þ 1b 8 þ 2a
GR 47 þ 8 35 þ 6 28 þ 4a
Distal colon MR 30 þ 6 20 þ 5d 16 þ 4b
GR 55 þ 7 42 þ 6 35 þ 5b
Adrenalectomized mice were treated for 5 h or 5 days with 5 mg/kg of L-(S,R)-BSO. Controls were injected with vehicle only. Organs
were removed, homogenized in bu¡er lacking DTT, and centrifuged. The speci¢c binding of [3H]ALDO to the MR and [3H]DEX to
the GR were measured in cytosolic fractions as described in Section 2. Results represent the mean (in fmol/mg) þ S.E.M. of six ani-
mals per group. Signi¢cantly di¡erent from control at aP6 0.001, bP6 0.005, cP6 0.010, dP6 0.015.
1 Note that values of steroid binding measured in colon (ex-
pressed per mg of protein) are signi¢cantly lower than values
reported by other groups [42] because we used crude cytosol
rather than cytosol from isolated colonic crypts as source of
receptors.
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by 20% the steroid binding capacity in kidney,
whereas V35% inhibition was measured for the oth-
er tissues, except hippocampus. Interestingly, in vitro
treatments with DTT (data not shown), as those per-
formed in the experiments shown in Fig. 4, fully
reversed the inhibition of the steroid binding capacity
of both the GR (in all tissues) and the MR (except in
kidney).
Taken together, these results obtained by oxidative
stress generated in vivo con¢rm previous observa-
tions performed in vitro which reported a lower sen-
sitivity for GR than for MR in a low redox potential.
This also suggests that the MR may be more sensi-
tive to an oxidative environment due to its structural
and/or regulatory features rather than a non-speci¢c
systemic failure due to the GSH depletion.
3.7. Sulfhydryl-modifying reagents inhibit the steroid
binding capacity of MR in a reversible manner
If the oxidation of thiol groups of MR is respon-
sible for the loss of steroid binding capacity, sulf-
hydryl-reacting reagents should exert similar e¡ects.
To con¢rm this hypothesis, mouse kidney cytosol
obtained in bu¡er lacking DTT was treated with ei-
ther NEM and DTNB (0.1 mM and 1.0 mM for 1 h
at 8‡C) to promote thiol alkylation, or with 5% H2O2
for 30 min at 8‡C to promote MR oxidation. A
steroid binding assay was then performed without
further treatment or after previous reincubation of
thiol-modi¢ed cytosol with 10 mM of DTT.
Fig. 5 shows that NEM, DTNB, and H2O2 inhib-
ited ALDO binding in a DTT-reversible manner,
suggesting a crucial role of reduced cysteines in the
MR for steroid binding. These results obtained with
mouse MR are consistent with previous observations
reported with rat MR [12,13] and recombinant hMR
[14]. Importantly, the inhibition obtained in vitro
with cysteine-reactive reagents resembles the e¡ects
observed in the aforementioned experiments where
oxidative stress was generated in vivo by depletion
of GSH.
3.8. GSH monoethyl ester reverses the inhibitory
e¡ect of L-(S,R)-BSO on the mineralocorticoid
activity
We then studied the in vivo capacity to recover
from the GSH depletion by co-treatment of
L-(S,R)-BSO with GSH or GSH monoethyl ester.
The mineralocorticoid biological e¡ect was measured
in mice injected with 2 Wg ALDO/100 g as described
for Fig. 1. Kidneys were excised quickly and the
levels of GSH were measured in cytosol. Due to
the presence of injected ALDO, the hormone binding
cannot be measured in the same animals, so a second
group of mice were treated in parallel (ALDO was
not injected) to evaluate the steroid binding capacity
in kidney cytosol. Results are shown in Table 3.
No signi¢cant di¡erences were obtained for min-
eralocorticoid action, steroid binding, and tissue
GSH levels in mice treated with the inactive diaste-
reoisomer L-(R)-BSO or in mice treated with reduced
GSH only. As expected, treatment with L-(S,R)-BSO
not only depleted GSH tissue levels, but also inhib-
ited both the ALDO-dependent mineralocorticoid ef-
fect and the steroid ALDO capacity in renal cytosol.
Co-treatments with reduced GSH were ine¡ective to
reverse these deleterious e¡ects. In contrast, co-treat-
ment with GSH monoethyl ester fully prevented the
toxic e¡ects of L-(S,R)-BSO by preserving the intra-
Fig. 5. Alkylation and oxidation inactivates mouse renal MR.
Kidney cytosol was obtained from adrenalectomized mice in
bu¡er lacking DTT. Alkylation of the MR (5 mg of cytosolic
proteins) was carried out for 1 h at 8‡C with either NEM or
DTNB (0.1 mM and 1.0 mM) and receptor oxidation was in-
duced in the presence of 5% v/v H2O2 for 30 min at 8‡C. A
steroid binding assay was then performed. Where indicated, al-
kylated or oxidized MR was reincubated in bu¡er supplemented
with 10 mM DTT for 30 min at 0‡C.
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cellular levels of GSH. As can be seen in controls
treated with GSH ester only or with L-(R)-BSO and
GSH ester, the mineralocorticoid function did not
undergo modi¢cations with respect to controls.
In order to con¢rm that the e¡ects observed on
mineralocorticoid function were due to GSH deple-
tion rather than unknown side e¡ects of the drug, we
depleted tissue levels of GSH by another method.
Thus, mice were injected with DEM, a compound
able to rapidly form GSH conjugates which are
transported out of cells without inhibiting the bio-
synthetic pathway [17,31]. Preliminary experiments
(not shown) demonstrated that the e¡ect of a single
i.p. injection of DEM (3 mmol/kg) resulted in a rapid
depletion of renal GSH after 1 h (from 2.1 to 0.2
Wmol/g). This depletion was rapidly reversed by re-
Table 4
Determination of reactive sulfhydryls in the MR immunoadsorbed from mouse renal cytosol after in vivo treatment with L-(S,R)-BSO
Treatment Thiols (Wmol/mg of protein) Percentage of the control
Vehicle 0.92 þ 0.06 100
L-(R)-BSO 0.85 þ 0.10 92
L-(S,R)-BSO (5 h) 0.44 þ 0.12** 48
L-(S,R)-BSO+GSH ester (5 h) 0.97 þ 0.10 105
L-(S,R)-BSO (5 days) 0.38 þ 0.05* 41
L-(S,R)-BSO+GSH ester (5 days) 1.03 þ 0.15 112
L-(S,R)-BSO (5 h)+DTT in vitro 1.08 þ 0.18 117
L-(S,R)-BSO (5 days)+DTT in vitro 0.77 þ 0.03*** 84
Adrenalectomized mice were treated for 5 days with 5.0 mmol/kg/day of L-(S,R)-BSO and/or 6 mmol/kg/day of GSH monoethyl ester.
Kidneys were then excised, homogenized, and the MR was immunoadsorbed from cytosols with pAbhMR antibody as described in
Section 2. The reactive sulfhydryl groups present in each stripped immunoadsorbed MR were quanti¢ed by duplicate with Ellman’s
reagent. In acute treatments, mouse kidneys were excised 5 h after the injection of a single dose of L-(S,R)-BSO and/or GSH mono-
ethyl ester. The reactivation of oxidized thiols was achieved by incubation of the immunoprecipitated MR with 2 mM DTT (30 min
at 0‡C) followed by three washes with bu¡er. Immunoadsorptions performed with non-immune rabbit serum were used as blanks and
subtracted from the respective A412 nm obtained with pAbhMR. A molar absorptivity of 13 600 M31 cm31 was used to quantify reac-
tive thiol groups. Results represent means þ S.E.M. for ¢ve mice per group. Di¡erent from control at: *P6 0.001; **P6 0.010;
***P6 0.015.
Table 3
Reversion of the inhibitory e¡ect of L-(S,R)-BSO on the mineralocorticoid function by GSH monoethyl ester
Treatment Na/K ratio [3H]ALDO bound (fmol/mg of protein) GSH (Wmol/g of tissue)
Vehicle 0.18 þ 0.03 45 þ 2 2.3 þ 0.3
L-(R)-BSO (5 days) 0.23 þ 0.04 40 þ 4 2.0 þ 0.2
L-(S,R)-BSO (5 days) 0.55 þ 0.04 20 þ 4 0.3 þ 0.1
L-(S,R)-BSO (5 h) 0.59 þ 0.12 25 þ 9 0.2 þ 0.2
GSH (5 days) 0.19 þ 0.05 49 þ 6 2.5 þ 0.3
GSH ester (5 days) 0.17 þ 0.02 47 þ 5 4.0 þ 0.4
L-(S,R)-BSO+GSH (5 days) 0.42 þ 0.06 28 þ 5 0.4 þ 0.2
L-(S,R)-BSO+GSH ester (5 days) 0.18 þ 0.04 42 þ 3 3.0 þ 0.3
L-(S,R)-BSO+GSH ester (5 days) 0.20 þ 0.02 46 þ 7 4.2 þ 0.7
L-(S,R)-BSO+GSH ester (5 h) 0.21 þ 0.05 45 þ 5 2.7 þ 0.4
DEM (2 h) 0.60 þ 0.02 18 þ 2 0.2 þ 0.1
DEM+GSH ester (2 h) 0.22 þ 0.05 40 þ 4 4.1 þ 0.6
Adrenalectomized mice were injected (i.m.) for 5 days at intervals of 12 h (8.00 and 20.00 h) with L-(S,R)-BSO or L-(R)-BSO (5 mmol/
kg/day). Controls were injected with vehicle. GSH or GSH monoethyl ester (6 mmol/kg/day) was also co-administered to some ani-
mals (9.00, 15.00 and 21.00 h). One group of mice was injected with a single dose of L-(S,R)-BSO and/or GSH ester and killed 5 h
later. Acute treatments with DEM (3 mmol/kg) were conducted as explained in the text. The in vivo mineralocorticoid e¡ect of 2 Wg/
100 g of ALDO was measured as urinary Na/K ratio. Kidneys were then excised, homogenized, and GSH levels and [3H]ALDO
binding capacity were measured. The Na/K ratio ranged between 1.69 þ 0.24 for all adrenalectomized mice injected with vehicle re-
gardless of the treatment considered. Results represent means þ S.E.M. of ¢ve animals per group.
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synthesis of GSH and 2.5 h after the administration
of DEM the tissue levels of GSH were similar to
those measured in the control. In the experiment
shown in Table 3, mice were pretreated with
3 mmol/kg of DEM (i.p.), this dose being repeated
after 1 h and 2 h. In parallel, another group of ani-
mals were co-treated with GSH ester (2.5 mmol/kg
co-administered with DEM).
Mice treated with DEM exhibited low levels of
GSH in kidney as well as an inhibited mineralocorti-
coid response to ALDO. The steroid binding ca-
pacity was also abolished. All these e¡ects were pre-
vented by co-treatment with GSH monoethyl ester,
demonstrating that the depletion of GSH was in ef-
fect responsible for abrogating the mineralocorticoid
e¡ect.
When tissue levels of GSH, ALDO binding ca-
pacity, and Na/K ratio are compared, signi¢cant
di¡erences (P6 0.001) are evidenced between the
control group and mice treated with L-(S,R)-BSO
(either co-treated or not with GSH) or DEM.
3.9. Oxidation of renal mineralocorticoid receptor in
L-(S,R)-BSO-treated mice
In order to provide direct molecular evidence for
receptor oxidation after GSH depletion, renal MR
was immunopuri¢ed from cytosol obtained from
L-(S,R)-BSO-treated mice and sulfhydryl groups
were quanti¢ed with Ellman’s reagent. To prevent
the interference of co-immunoprecipitated proteins
which belong to the steroid receptor heterocomplex
(i.e. hsp90, p23, immunophilins, etc.) we stripped the
immunoprecipitated receptor by incubation with
high ionic strength. Immunoprecipitations performed
with non-immune rabbit serum were used as blanks
(A412 nm = 0.02) and subtracted from the A412 nm ob-
tained for each immunopellet. Results shown in Ta-
ble 4 demonstrate that MR isolated from 5 h or 5 day
treated mice yielded V40^50% of reactive sulf-
hydryls as compared to untreated control. Consistent
with the results presented in Table 3, co-treatment
with GSH monoethyl ester fully preserved the thiol
reactivity. In vitro reduction of the MR in the pres-
ence of DTT reversed the number of reactive sulf-
hydryls to control levels in acutely treated mice. In
contrast, only a partial reversion (84% of the control,
P6 0.015) was obtained with reincubated MR iso-
lated from long-term treated animals. This observa-
tion is consistent with that analyzed in Fig. 4. No
di¡erences were obtained in the thiol reactivity when
Ellman’s reaction was performed in the absence of
detergent (data not shown), evidencing that total and
available protein sulfhydryls are indistinguishable.
To provide direct evidence that the inhibition of
the mineralocorticoid e¡ect may be due to the inabil-
ity of oxidized MR to bind steroid, we used
[3H]DEX-mesylate as ligand. This synthetic steroid
plays a double role of ligand and sulfhydryl reagent
able to bind covalently to the steroid binding pocket
of the receptor. Despite the fact that DEX-mesylate
exhibits a 300-fold higher a⁄nity for the GR
(Kd = 0.2 nM) than for the MR (Kd = 62 nM), under
conditions where the binding to the GR is blocked
(i.e. in the presence of 100-fold excess of RU486) a
signi¢cant steroid binding to the MR can be expected
for a tracer concentration equal to 300 nM (83% of
maximum binding for MR). Inasmuch as the GR is
cleared from cytosol by speci¢c immunoadsorption
with BuGR2 antibody and the MR is then immuno-
puri¢ed with pAbhMR antibody, it can be predicted
that the radioactivity associated with the pAbhMR
immunopellet is due to steroid binding to MR. In
e¡ect, we have previously demonstrated [11] that
there is no detectable amount of GR in kidney cyto-
sol after three cycles of immunoadsorption with
BuGR2. Accordingly, the levels of GR associated
with [3H]DEX-mesylate which were recovered after
this treatment accounted for less than 5% of total
radioactivity bound to the MR (data not shown).
In addition, preliminary experiments performed in
this work evidenced that the GR immunoadsorbed
with BuGR2 was not labelled with [3H]DEX-mesy-
late when kidney cytosol was incubated with [3H]
tracer in the presence of 30 WM RU486, demonstrat-
ing that under this experimental condition there is a
full blockade of the GR. Therefore, the radioactivity
associated with the pAbhMR immunopellet is cer-
tainly due to the [3H]DEX-mesylate/MR complex.
Fig. 6A depicts autoradiograms of immunopuri¢ed
MR labelled with [3H]DEX-mesylate. Lane 1 shows
no radioactivity in the pellet obtained with non-im-
mune serum. Lane 2 shows a radioactive band in the
immunopellet recovered from cytosol labelled with
[3H]DEX-mesylate in the absence of RU486. This
band was not observed when 170-fold excess of ra-
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dioinert ALDO was added to the incubation medium
(lane 3), demonstrating that the tracer is speci¢cally
bound to the steroid binding site of the MR. Lane 4
shows a radioactive band in the immunopellet ob-
tained from cytosol labelled in the presence of 100-
fold excess of RU486. Since densitometric scanning
revealed that this band is not di¡erent from that
observed in lane 2, we conclude that the autoradio-
gram shows the radioactive bands of [3H]DEX-me-
sylate speci¢cally bound to the MR. Nevertheless, we
decided to conserve RU486 in the labelling medium
for the next experiment to prevent any non-speci¢c
signal due to putative contamination with renal GR.
As previously shown in Fig. 4, reincubation of
cytosol with DTT failed to recover all of the steroid
binding capacity in renal cytosol obtained from mice
treated with L-(S,R)-BSO for 5 days. Furthermore,
Scatchard analysis performed with these preparations
demonstrated that the total number of binding sites
was decreased. This observations may be due to: (a)
a certain percentage of oxidized MR present in the
cells may be irreversibly inactivated, or (b) the con-
centration of receptor protein is decreased due to a
generalized failure in protein synthesis and/or in-
creased degradation. The experiment shown in Fig.
6B suggests that the former hypothesis is most likely.
The upper bands correspond to an autoradiogram of
immunopuri¢ed MR labelled with [3H]DEX-mesy-
late, whereas the lower bands show the Western
blot developed with horseradish peroxidase. Lane 1
is an adsorption performed with a non-immune se-
rum, lanes 2^4 are immunoadsorptions performed
with cytosols obtained from mice treated for 5 days
with vehicle (lane 2), L-(S,R)-BSO (lane 3), and L-
(S,R)-BSO plus GSH monoethyl ester. Densitometric
scanning revealed that the relative densities of radio-
activity are 1.00/0.43/1.22 for lanes 2, 3, and 4. The
density ratios normalized as autoradiography signal/
Western blot signal are respectively 1.00/0.44/0.96.
These results are indicative that the concentration
of receptor protein present in the kidney of
L-(S,R)-BSO-treated mice does not decrease after
5 days of treatment, and also con¢rm the postulate
that the binding of the ligand is abrogated because
the MR is oxidized.
3.10. Depletion of GSH does not signi¢cantly a¡ect
the activity of proteins involved in the
mineralocorticoid biological response
As noted in Section 1, the mineralocorticoid action
involves proteins related to ion transport, energy me-
tabolism, and glucocorticoid inactivating enzymes. In
order to assess the e¡ect of GSH depletion on the
normal function of these proteins, we measured the
Fig. 6. Covalent binding of sulfhydryl-reactive ligand to renal
mouse MR. (A) Immunoadsorption of mouse MR. Renal cyto-
sol was labelled with 300 nM [3H]DEX-mesylate for 3 h at 0‡C
as described in detail in Section 2. After adsorption of free li-
gand with charcoal/dextran, cytosols were precleared of GR
with BuGR2 antibody and the MR was then immunoprecipi-
tated with pAbhMR antibody (lanes 2^4). The immunopellets
were analyzed by Western blot with 0.1% pAbhMR. Lane 1:
immunoadsorption performed with non-immune rabbit serum.
Lane 2: immunopellet from labelled cytosol. Lane 3: immuno-
pellet from cytosol labelled in the presence of 50 WM radioinert
ALDO. Lane 4: immunopellet from cytosol labelled in the pres-
ence of 30 WM radioinert RU486. (B) Immunopuri¢cation of la-
belled MR obtained from L-(S,R)-BSO-treated mice. Mice were
treated with 5 mmol/kg/day of L-(S,R)-BSO for 5 days. Kidney
cytosol was labelled with 300 nM [3H]DEX-mesylate for 3 h at
4‡C in the presence of 30 WM RU486. Labelled MR was specif-
ically immunoprecipitated as explained for panel A, Western
blotted (lower lane), and autoradiographed (upper lane). Condi-
tions are: Lane 1: immunoadsorption performed with rabbit
non-immune serum. Lane 2: MR from untreated mice. Lane 3:
MR from L-(S,R)-BSO-treated mice. Lane 4: MR from mice
cotreated with L-(S,R)-BSO and GSH monoethyl ester.
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activity of ATPases, citrate synthase, and 11L-hy-
droxysteroid dehydrogenase in kidney distal tubules
isolated from normal and L-(S,R)-BSO-treated mice.
We also measured the number of NaK pumps by
binding of [3H]ouabain, and the number of Na/
H antiport by binding of [14C]amiloride. Results
are shown in Table 5. As can be seen, only the num-
ber of total NaK pumps was signi¢cantly a¡ected in
kidney obtained from long-term treated mice. Even
when the Na,K-ATPase activity measured in this
group was similar to the untreated control group,
the [3H]ouabain binding was 30% higher, suggesting
that the normal Na,K-ATPase activity was preserved
by increasing the total number of pumps.
4. Discussion
Our results strongly support the notion that the in
vivo oxidation of the renal MR leads to an abro-
gated mineralocorticoid biological response as a con-
sequence of the inability of the receptor to bind ago-
nist. Extensive studies have revealed that oxidized
proteins are recognized by proteases and completely
degraded (see [32] for a review); however, this may
not be the case for the oxidative MR inactivation
observed for long-term treatment with L-(S,R)-BSO.
We have previously demonstrated [12] that, even
when oxidized rat MR is unable to bind steroid, it
is much more stable to thermal degradation in a cell-
free system than the ‘reduced’ form of MR. Accord-
ing to those experiments, sulfhydryl reagents abol-
ished the steroid binding ability of MR in a com-
pletely reversible manner upon the addition of
reducing agents after incubations at 25‡C, a temper-
ature which allows extensive proteolysis in a cell-free
system. In the present report, we provide direct evi-
dence that the receptor protein remains stable in a
non-reducing environment, although it is unable to
bind ligand.
In all the cases studied here, the harmful e¡ects on
the mineralocorticoid response generated by GSH
depletion were fully prevented by co-treatment with
GSH ester, reinforcing the concept that oxidative
stress inhibits the MR-dependent biological response.
In vitro studies performed previously on native rat
MR and recombinant hMR demonstrated that a low
redox potential greatly a¡ects the steroid binding
capacity [12,14,15]. The essential role of cysteines in
MR for ligand binding was demonstrated in native
rat receptor by conventional biochemical approaches
[12,13] and in overexpressed recombinant receptor by
site-directed mutagenesis studies [14]. Therefore, a
deleterious e¡ect upon oxidative stress was inferred
from those studies. In this work, we show that these
structural studies correlate with the in vivo biological
response, a situation where the MR is not only regu-
lated in its own physiological milieu, but more im-
portantly where compensatory mechanisms may be
triggered as a direct response to the oxidative stress.
One example of these compensatory mechanisms
may be found in the fact that the total activity of
Na,K-ATPase is not altered after 5 days of GSH
depletion. However, this is achieved by increasing
the number of pumps, as evidenced in Table 5.
Therefore, a proportional decrease in the speci¢c ac-
tivity of these pumps may be inferred.
It has been reported [33] that the full-length im-
Table 5
E¡ect of L-(S,R)-BSO on kidney distal tubule
Parameter Control +L-(S,R)-BSO
5 h 5 days
Citrate synthase (Wmol/mg per min) 2.42 þ 0.21 2.72 þ 0.44 2.33 þ 0.31
11L-Hydroxysteroid dehydrogenase (Wmol/mg per min) 4.66 þ 0.53 4.44 þ 0.60 4.27 þ 0.92
Total ATPase (Wmol/mg per min) 1.93 þ 0.14 1.81 þ 0.15 1.72 þ 0.22
Na,K-ATPase (Wmol/mg per min) 0.47 þ 0.06 0.39 þ 0.06 0.48 þ 0.03
[3H]Ouabain binding (cpm/mg) 488 þ 31 440 þ 41 646 þ 45*
[3H]Amiloride binding (cpm/mg) 377 þ 26 360 þ 50 366 þ 42
Adrenalectomized mice were treated for 5 h or 5 days with 5 mg/kg of L-(S,R)-BSO, kidney distal tubules were then isolated, and
some proteins were analyzed. Animals from the control group were injected with vehicle only. Results were normalized by mg of pro-
tein and shown as means þ S.E.M. of ¢ve mice per group. *Signi¢cantly di¡erent from control at P6 0.010.
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munoreactive estrogen receptor can be extracted
from primary human breast cancer tumors. How-
ever, this intact receptor is unable to bind to its cog-
nate estrogen response element. Interestingly, this ef-
fect was reversed by incubation with an excess of
DTT. These results not only demonstrate that the
oxidized protein is not cleaved, but also suggest
that the transactivational activity of the estrogen re-
ceptor may be modulated by changes in the intra-
cellular redox potential.
The role of a reducing milieu on steroid receptors
has also been demonstrated for the GR in experi-
ments performed in vitro. It is known that the ex-
traction of rat liver cytosol with charcoal inactivates
the glucocorticoid binding capacity and receptors can
be reactivated to the steroid binding state by an en-
dogenous NADPH reducing system and an endoge-
nous heat-stable activating factor identi¢ed as thio-
redoxin (reviewed in [34]).
Recently, we demonstrated that S-nitrosylation of
the GR by nitric oxide decreases the steroid binding
capacity [35]. This inhibition does not occur if the
GR is previously bound to the ligand or when the
redox potential of the medium is lowered. We con-
cluded that the presence of steroid in the hormone
binding pocket prevented such S-nitrosylation, and
this led us to speculate about why glucocorticoids
fail to exert their e¡ects in septic shock, a situation
where signi¢cant amounts of nitric oxide are gener-
ated. Consistent with this idea, glucocorticoids are
bene¢cial in the treatment of this pathological con-
dition if they are administered previous to the onset
of septic shock.
It is known that the DNA binding domain of
many transcription factors (steroid receptors, AP-1,
p53, c-myb, NF-UB, Sp-1, E2, etc.) are also redox-
sensitive, mainly via oxidation/reduction of critical
cysteine residues within their zinc-¢nger loops
[36,37]. There are also essential cysteines in the hor-
mone binding domain of the steroid receptors. How-
ever, the sensitivity to oxidation of those amino acids
in, i.e., the estrogen receptor [33] or the GR [35,38],
is not as evident as in the MR. Thus, the hormone
binding is abolished upon receptor alkylation or
treatment with H2O2 in all the steroid receptors,
but under more drastic conditions than those re-
quired for the MR. This suggests that thiol groups
involved in the steroid binding domain may be more
protrusive in the MR than in the other steroid re-
ceptors. This hypothesis is also supported by the ex-
periments shown here in Table 2.
It is recognized that GSH can protect cells against
oxidation, heavy metal ions, radiation, and certain
toxic compounds [16]. Such protection is abolished
by GSH depletion. In this sense, L-(S,R)-BSO seems
to be a very useful and speci¢c tool to study the
GSH action. It has been reported that treatments
with L-(S,R)-BSO were also e¡ective to deplete
GSH in newborn rats, adult mice, guinea pigs, and
human cells [17,39^41]. Consistent with those studies,
we show here that co-treatment with GSH ester was
e¡ective in increasing tissue GSH levels and, more
importantly, in recovering the mineralocorticoid re-
sponse in mice treated with L-(S,R)-BSO. On the
other hand, treatment with GSH was ine¡ective.
This may be ascribed to the fact that when the gly-
cine carboxyl group of GSH is esteri¢ed the molecule
exhibits better properties for GSH delivery and a
slower rate of extracellular breakdown [16].
Our results provide clear evidence that the oxida-
tive stress generated by tissue depletion of gluta-
thione abrogates the in vivo biological response trig-
gered by ALDO, mainly due to the fact that oxidized
renal MR is unable to bind steroid. Inasmuch as
glutathione depletion is systemic (Table 1), it is en-
tirely possible that a similar mechanism of inhibition
for the MR-dependent biological response may take
place in other target organs which also express the
MR, such as those studied in Table 2. One question
which still remains unanswered is whether the rever-
sible inactivation of the MR by oxidation is simply
the obvious consequence of the amino acid modi¢-
cation under certain abnormal circumstances or is
part of a more sophisticated mechanism to regulate
receptor availability.
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